Global Pre-Exposure Prophylaxis Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ1028310 No. of Pages: 112 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global Pre-Exposure Prophylaxis market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period between 2021 and 2027.
This report studies the Pre-Exposure Prophylaxis market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Pre-Exposure Prophylaxis in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Truvada
Discovy
Market Snapshot, By Application
Adult
Adolescent
Main Market Players Analyzed in this report, including:
Teva Pharmaceuticals
Strides Pharma Science
Lupin
Gilead Sciences
The study objectives of this report are:
To study and analyze the global Pre-Exposure Prophylaxis market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Pre-Exposure Prophylaxis market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Pre-Exposure Prophylaxis manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pre-Exposure Prophylaxis market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Pre-Exposure Prophylaxis submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Pre-Exposure Prophylaxis are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Pre-Exposure Prophylaxis Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Pre-Exposure Prophylaxis Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Pre-Exposure Prophylaxis
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Pre-Exposure Prophylaxis Sales Channel and Distributors Analysis
3.3.1 Pre-Exposure Prophylaxis Sales Channel
3.3.2 Pre-Exposure Prophylaxis Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Adult
3.4.2 Major Buyers in Adolescent
3.5 Pre-Exposure Prophylaxis Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Pre-Exposure Prophylaxis Type Introduction
4.1.1 Truvada
4.1.2 Discovy
4.2 Global Pre-Exposure Prophylaxis Sales by Type 2016-2021
4.3 Global Pre-Exposure Prophylaxis Revenue by Type 2016-2021
4.4 Global Pre-Exposure Prophylaxis Price by Type 2016-2021
5 Market Segment: by Application
5.1 Pre-Exposure Prophylaxis Type Introduction
5.1.1 Adult
5.1.2 Adolescent
5.2 Global Pre-Exposure Prophylaxis Sales by Application 2016-2021
5.3 Global Pre-Exposure Prophylaxis Revenue by Application 2016-2021
5.4 Global Pre-Exposure Prophylaxis Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Pre-Exposure Prophylaxis Market by Region
6.1.1 Global Pre-Exposure Prophylaxis Sales by Regions
6.1.2 Global Pre-Exposure Prophylaxis Revenue by Regions
6.2 North America Pre-Exposure Prophylaxis Market 2016-2021
6.3 Europe Pre-Exposure Prophylaxis Market 2016-2021
6.4 Asia Pacific Pre-Exposure Prophylaxis Market 2016-2021
6.5 South America Pre-Exposure Prophylaxis Market 2016-2021
6.6 Middle East and Africa Pre-Exposure Prophylaxis Market 2016-2021
7 North America
7.1 North America Pre-Exposure Prophylaxis Market by Country 2016-2021
7.1.1 North America Pre-Exposure Prophylaxis Sales by Country
7.1.2 North America Pre-Exposure Prophylaxis Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Pre-Exposure Prophylaxis Market by Country 2016-2021
8.1.1 Europe Pre-Exposure Prophylaxis Sales by Country
8.1.2 Europe Pre-Exposure Prophylaxis Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Pre-Exposure Prophylaxis Market by Country 2016-2021
9.1.1 Asia Pacific Pre-Exposure Prophylaxis Sales by Country
9.1.2 Asia Pacific Pre-Exposure Prophylaxis Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Pre-Exposure Prophylaxis Market by Country 2016-2021
10.1.1 South America Pre-Exposure Prophylaxis Sales by Country
10.1.2 South America Pre-Exposure Prophylaxis Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Pre-Exposure Prophylaxis Market by Country 2016-2021
11.1.1 Middle East and Africa Pre-Exposure Prophylaxis Sales by Country
11.1.2 Middle East and Africa Pre-Exposure Prophylaxis Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Teva Pharmaceuticals
12.1.1 Teva Pharmaceuticals
Company Information
12.1.2 Teva Pharmaceuticals
Pre-Exposure Prophylaxis Product Portfolio, Specification and Application
12.1.3 Teva Pharmaceuticals
Pre-Exposure Prophylaxis Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Teva Pharmaceuticals
Key Development
12.2 Strides Pharma Science
12.2.1 Strides Pharma Science
Company Information
12.2.2 Strides Pharma Science
Pre-Exposure Prophylaxis Product Portfolio, Specification and Application
12.2.3 Strides Pharma Science
Pre-Exposure Prophylaxis Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Strides Pharma Science
Key Development
12.3 Lupin
12.3.1 Lupin
Company Information
12.3.2 Lupin
Pre-Exposure Prophylaxis Product Portfolio, Specification and Application
12.3.3 Lupin
Pre-Exposure Prophylaxis Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Lupin
Key Development
12.4 Gilead Sciences
12.4.1 Gilead Sciences
Company Information
12.4.2 Gilead Sciences
Pre-Exposure Prophylaxis Product Portfolio, Specification and Application
12.4.3 Gilead Sciences
Pre-Exposure Prophylaxis Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Gilead Sciences
Key Development
13 Global Pre-Exposure Prophylaxis Market Forecast by Region by Type and by Application
13.1 Global Pre-Exposure Prophylaxis Sales, Revenue Forecast 2022-2027
13.2 Global Pre-Exposure Prophylaxis Forecast by Regions
13.2.1 Global Pre-Exposure Prophylaxis Sales Forecast by Region 2022-2027
13.2.2 Global Pre-Exposure Prophylaxis Revenue Forecast by Region 2022-2027
13.3 Global Pre-Exposure Prophylaxis Forecast by Type
13.3.1 Global Pre-Exposure Prophylaxis Sales Forecast by Type 2022-2027
13.3.2 Global Pre-Exposure Prophylaxis Revenue Forecast by Type 2022-2027
13.3.3 Global Pre-Exposure Prophylaxis Price Forecast by Type 2022-2027
13.4 Global Pre-Exposure Prophylaxis Forecast by Application
13.4.1 Global Pre-Exposure Prophylaxis Sales Forecast by Application 2022-2027
13.4.2 Global Pre-Exposure Prophylaxis Revenue Forecast by Application 2022-2027
13.4.3 Global Pre-Exposure Prophylaxis Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com